
Sign up to save your podcasts
Or


Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option.
Study: https://www.nejm.org/doi/10.1056/NEJMoa2503531
JC Companion: https://autoimmunedevreport.substack.com/
By Michael Putman4.9
114114 ratings
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option.
Study: https://www.nejm.org/doi/10.1056/NEJMoa2503531
JC Companion: https://autoimmunedevreport.substack.com/

504 Listeners

298 Listeners

128 Listeners

3,374 Listeners

1,150 Listeners

120 Listeners

194 Listeners

518 Listeners

68 Listeners

5 Listeners

375 Listeners

183 Listeners

188 Listeners

19 Listeners

6 Listeners